Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    France Germany Italy Spain
  • Study on Atezolizumab and Bevacizumab for Patients with Unresectable Liver Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study of lenvatinib treatment benefits in patients with non-resectable liver cancer (hepatocellular carcinoma) who are on liver transplant waiting list after unsuccessful TACE therapy

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on the Safety and Effects of Durvalumab, Tremelimumab, and Bevacizumab in Patients with Advanced Liver Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Italy
  • Study on Cabozantinib for Patients with Liver Cancer Not Responding to Previous Immune Treatments

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study on the Effectiveness and Safety of Nofazinlimab and Lenvatinib for Patients with Advanced Liver Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland Spain